Pulsed Eco Doppler for Polmonal Discharge Velocity

NCT ID: NCT06815198

Last Updated: 2025-02-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-05-06

Study Completion Date

2025-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chest ultrasound is increasingly being used in the diagnosis and management of the respiratory patient. With ultrasound, ultrasound artifacts representing the lung during inspiration and during exhalation are visualized and analyzed. During inspiration, the lung inflates with air while when exhaling, the lung empties. These two phases are visualized on ultrasound with a sliding motion of the pleural line, which represents the margin of the lung.

The aim of the study is to identify the speed of filling and emptying of the lung by studying the characteristics of the pulsed Doppler wave to measure the speed of lung sliding as the significance of this finding has not yet been clarified. In both healthy subjects and patients with lung disease, it is not known whether there is a correlation between velocity measured by the Doppler wave with the main data recorded by a mechanical ventilator or spirometer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the context of trauma, lung ultrasound has proven to be an indispensable tool for identifying pneumothorax. Two ultrasound signs confirm the presence of pnx : the absence of pleural gliding and the finding of the lung point, which is the point where the partially collapsed lung regains contact with the pleural leaflets. However, it is not always easy to be able to detect these two signs especially in the field of urgency-emergency, which is why the authors of the extended focused assessment sonography for trauma (EFAST) proposed to include in the extended ultrasound study the use of Color Doppler by attributing the terms "power slide" to confirm the presence of pleural motion and be able to exclude pneumothorax. The use of Color Doppler has always been used for the identification of blood vessels based on the movement of blood flow. The unusual use of Color Doppler in this context finds its rationale in the physical principle that the Doppler wave senses the motion of approaching and receding from the probe regardless of whether the insonated object is a vascular structure or a biological tissue.

The literature shows that pulmonary Doppler was used in a pilot study to analyze pulmonary vessels in healthy individuals and compare it with individuals in whom pulmonary embolism was established by CT angiography.

In contrast, the use of pulsed Doppler or tissue Doppler to measure the rate of lung parenchyma sliding has not yet been investigated.

Therefore, it is unclear whether pulsed Doppler can measure the velocity of lung gliding and whether this measurement correlates with flow values collected during a spirometric examination in healthy or affected volunteer subjects in spontaneous breathing or during mechanical ventilation in intubated subjects. It is unknown whether there is a correlation between the velocimetric parameters generated by the Doppler wave with the main ventilatory parameters (Current Volume, Compliance, Plateau pressure, PEEP, Driving pressure constant Tau). There is currently no correlation between B-mode ultrasound pathological patterns with velocimetry data.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

LUNG

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

The first group will include subjects without pulmonary disease who will be admitted to the pulmonology outpatient clinic, where they will undergo respiratory function and ultrasound tests simultaneously by two operators respectively

No interventions assigned to this group

Group 2

The second group includes three subgroups of patients:

2a) Patients with chronic respiratory diseases referred to the Respiratory Diseases Unit of this Polyclinic classified according to the type of disease: COPD, Idiopathic Pulmonary Fibrosis, Pneumonia, Asthma in good control and exacerbation, neuromuscular diseases, ARDS (group2a).

2b) The patients without pulmonary diseases and undergoing elective surgery mechanically ventilated (group2b).

2c) The patients with pulmonary diseases undergoing surgery in the operating room surgery and/or admitted to the Multipurpose Intensive Care Unit and Respiratory Intensive Care Unit of this Polyclinic undergoing mechanical ventilation, categorized according to the type of lung disease specified in the previous point(group2c).

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \>= 18 years
* Acquisition of Informed Consent

Exclusion Criteria

* Patients admitted to undergo major thoracic surgery.
* Remote pathological history positive for recurrent PNX (≥ 2), pleural thalking or pleurodesis
* Patients presenting with absolute and relative contraindications to spirometry for1 and 2a patients ie:

recent myocardial infarction (within the past 3 months) or unstable angina hemoptysis thoracic aortic aneurysm
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tommaso Tonetti, MD

Role: PRINCIPAL_INVESTIGATOR

IRCCS Azienda Ospedaliero-Universitaria di Bologna - Anestesiologia e Terapia Intensiva Polivalente

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'Orsola, UOC Anestesiologia e Terapia Intensiva Polivalente

Bologna, , Italy

Site Status RECRUITING

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, UO Pneumologia

Bologna, , Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tommaso Tonetti, MD

Role: CONTACT

051 214 4309

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Tommaso Tonetti, MD

Role: primary

051 214 4309

Lara Pisani, MD

Role: primary

0512143257

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

VeLung

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.